Unichem Laboratories Limited has received ANDA approval for its Allopurinol Tablets, USP 100 mg and 300 mg from the United States Food and Drug Administration (USFDA) to market a generic version of ZYLOPRIM® (allopurinol) Tablets, which are indicated for the management of patients:
- with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destrcction, uric acid lithiasis, and/or nephropathy).
- with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels.
- with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients.
The Product will be commercialized from Unichem's Ghaziabad Plant.
Shares of UNICHEM LABORATORIES LTD. was last trading in BSE at Rs.204.75 as compared to the previous close of Rs. 202.4. The total number of shares traded during the day was 20113 in over 360 trades.
The stock hit an intraday high of Rs. 207.7 and intraday low of 200.45. The net turnover during the day was Rs. 4122206.